Nisa Investment Advisors
STOK icon

Nisa Investment Advisors’s Stoke Therapeutics STOK Stock Holding History

Nisa Investment Advisors’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$92.4K Buy
2,838
+402
+17% +$13.2K ﹤0.01% 1457
2025
Q4 		$77.3K Sell
2,436
-296
-11% -$8.9K ﹤0.01% 1511
2025
Q3 		$64.2K Hold
2,732
– – ﹤0.01% 1561
2025
Q2 		$31K Sell
2,732
-28
-1% -$266 ﹤0.01% 1739
2025
Q1 		$18.4K Buy
2,760
+56
+2% +$522 ﹤0.01% 1916
2024
Q4 		$29.8K Buy
2,704
+10
+0.4% +$123 ﹤0.01% 1812
2024
Q3 		$33.1K Sell
2,694
-295
-10% -$4.18K ﹤0.01% 1750
2024
Q2 		$40.4K Buy
2,989
+1,038
+53% +$14K ﹤0.01% 1726
2024
Q1 		$26.3K Buy
1,951
+17
+0.9% +$103 ﹤0.01% 1804
2023
Q4 		$10.2K Buy
1,934
+1,869
+2,875% +$7.99K ﹤0.01% 2041
2023
Q3 		$256 Buy
65
+17
+35% +$112 ﹤0.01% 2633
2023
Q2 		$510 Sell
48
-800
-94% -$8.51K ﹤0.01% 2555
2023
Q1 		$7K Buy
848
+800
+1,667% +$7.22K ﹤0.01% 2210
2022
Q4 		$0 Buy
+48
New +$499 ﹤0.01% 2714

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Nisa Investment Advisors's STOK Position: Q1 2026 in Review

Nisa Investment Advisors increased its Stoke Therapeutics (STOK) stake by 17% in Q1 2026, buying an estimated $13.2K and bringing the position to 2,838 shares worth $92.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1457.

Nisa Investment Advisors first reported a position in STOK in Q4 2022 and has held it in 14 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Nisa Investment Advisors held 2,838 shares of Stoke Therapeutics worth $92.4K as of Q1 2026.
  • Nisa Investment Advisors bought 402 Stoke Therapeutics shares in Q1 2026, an estimated $13.2K.
  • Stoke Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1457 holding.
  • Nisa Investment Advisors first reported a position in Stoke Therapeutics in Q4 2022 and has held it in 14 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.